Construction of an Early Recurrence Prediction Model and Real-World Efficacy of Adjuvant Chemoimmunotherapy in High-Risk Biliary Tract Cancer
This study developed and validated a nomogram incorporating multidimensional features like LODDS and SII to predict early recurrence in high-risk biliary tract cancer, while real-world evidence demonstrated that adjuvant chemoimmunotherapy significantly reduces the risk of early postoperative recurrence compared to surgery alone or chemotherapy.